IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.
IN8Bio has raised $20.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
IN8Bio's investors include Coastlands Capital, Bios Partners, Stonepine Capital Management, 683 CAPITAL.
IN8Bio is headquartered in New York, United States.
IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.
IN8Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IN8Bio — Funding & Investors." VCBacked, December 19, 2025, https://www.vcbacked.co/company/in8bio. Accessed October 3, 2026.
VCBacked. (2025). IN8Bio — Funding & Investors. Retrieved October 3, 2026, from https://www.vcbacked.co/company/in8bio
{{cite web |title=IN8Bio — Funding & Investors |url=https://www.vcbacked.co/company/in8bio |website=VCBacked |access-date=October 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated